Specjalistyczne Gabinety Lekarskie Landa

At Specjalistyczne Gabinety Lekarskie Landa in Kraków, much of the clinical research focuses on digestive system diseases, especially ulcerative colitis and Crohn’s disease. These studies are designed to assess new treatments, improve long-term disease control, and better understand how to achieve remission in people living with inflammatory bowel disease.

• Research in ulcerative colitis and Crohn’s disease
• Evaluation of new therapies for moderately to severely active IBD
• Studies aimed at improving remission, response, and ongoing disease management

The site is active in both treatment-testing and maintenance-focused research, with the goal of helping patients achieve more durable control of chronic intestinal inflammation.

The research portfolio also includes immune system diseases, with several trials centered on moderate to severe plaque psoriasis. These studies are exploring whether newer therapies can reduce symptoms, improve skin clearance, and provide better options for people whose disease has not responded well to standard care.

• Trials in moderate to severe plaque psoriasis
• Testing treatments that target immune-driven inflammation
• Focus on symptom improvement and treatment effectiveness

This area reflects a broader interest in immune-mediated conditions and how targeted therapies may offer more precise disease control.

Clinical trials at this site also cover nervous system diseases, including refractory focal onset epilepsy, stereotypical prolonged seizure, and migraine. The main purpose of this research is to evaluate whether new or existing treatments can help stop seizures faster, reduce seizure frequency, and prevent migraine attacks.

• Studies in epilepsy and prolonged seizure episodes
• Research on migraine prevention
• Assessment of safety, tolerability, and symptom control

These trials are especially relevant for patients with difficult-to-control neurological conditions who may need more effective treatment options.

The site is also involved in research on nutritional and metabolic diseases, including type 2 diabetes mellitus. These studies are aimed at evaluating whether new therapies can improve blood sugar control and support better day-to-day management of this common chronic condition.

• Trials in type 2 diabetes mellitus
• Testing approaches to improve glycemic control
• Focus on treatment effectiveness and patient-friendly disease management

This research adds another important dimension to the site’s work, extending beyond inflammatory and neurological diseases to long-term metabolic care.